| Product Name | MF | CAS | Details |
|---|
| CDK9-IN-23 | C22H25ClN4O3 | 2761572-96-5 | Details |
| PRMT5-IN-28 | C18H19ClN4O5 | 2242753-66-6 | Details |
| ATR-IN-29 | C19H22N8O | 2761193-67-1 | Details |
| Bcl-2-IN-11 | C45H49ClFN7O8S | 2760536-88-5 | Details |
| BTK-IN-25 | 2562351-92-0 | Details |
| PROTAC IRAK4 degrader-8 | C43H50ClF2N11O5 | 2911615-06-8 | Details |
| RSV L-protein-IN-5 | 851658-28-1 | Details |
| Topoisomerase II inhibitor 15 | 451516-79-3 | Details |
| AMPA receptor modulator-5 | C20H12F4N6 | 2034182-22-2 | Details |
| CBP/p300-IN-21 | C19H16NO4.Cl | 1065581-69-2 | Details |
| Estrogen receptor modulator 8 | 2170766-56-8 | Details |
| IIIM-8 | C14H17NO4 | 1128053-62-2 | Details |
| NWP-0476 | C47H53ClN8O8S | 2290611-26-4 | Details |
| THR-β modulator-1 | 2770373-00-5 | Details |
| FEN1-IN-6 | C12H8N2O5S2 | 824983-84-8 | Details |
| Tuberculosis inhibitor 7 | C21H18FN3O2S | 121041-20-1 | Details |
| TMV-IN-5 | C22H23N3S | 1207318-92-0 | Details |
| BACE1-IN-13 | C20H17FN8O2 | 1397683-26-9 | Details |
| ATR-IN-22 | C25H31N7O | 2905312-07-2 | Details |
| AXL-IN-15 | 1954722-22-5 | Details |
| CDK4-IN-2 | 2380320-68-1 | Details |
| CT1113 | C25H29N5O2S | 2523435-18-7 | Details |
| DNA-PK-IN-10 | 2919315-89-0 | Details |
| PCSK9-IN-15 | 2455423-94-4 | Details |
| Syk-IN-8 | C23H26N10 | 2568963-01-7 | Details |
| WM-586 | C20H20F3N5O3S | 2894832-05-2 | Details |
| SP-2-225 | C28H34N2O3 | 2364448-93-9 | Details |
| Antibacterial agent 154 | 2163048-45-9 | Details |
| Antifungal agent 66 | 1613152-33-2 | Details |
| DCLK1-IN-2 | C26H32N8O3S | 2978517-43-8 | Details |
| FD1024 | C21H20F2N4O2S | 1422456-47-0 | Details |
| Hedgehog IN-2 | 1126365-74-9 | Details |
| JAK1-IN-10 | 2416858-88-1 | Details |
| M867 | C27H43N7O6 | 680999-39-7 | Details |
| Y18501 | 2410627-32-4 | Details |
| Sirt1/2-IN-2 | C18H14N4O3S2 | 670267-73-9 | Details |
| IpOHA | C5H9NO4 | 132418-03-2 | Details |
| PCSK9-IN-14 | C15H10F6N4O2 | 2913198-84-0 | Details |
| 1-Isopropyltryptophan | 1219485-46-7 | Details |
| AMPA receptor modulator-6 | C24H36N2O4S2 | 516491-33-1 | Details |
| Anticancer agent 127 | C26H37FN4O6S | 2410953-19-2 | Details |
| BT424 | C22H15BCl2N2O2 | 2755180-37-9 | Details |
| IACS-52825 | C16H13F7N4O2 | 2640376-72-1 | Details |
| JAK-IN-27 | C20H21F2N7O | 2673176-36-6 | Details |
| RSV L-protein-IN-2 | C32H36N4O5 | 774130-99-3 | Details |
| TRPC3/6-IN-2 | 2387893-55-0 | Details |
| YXG-158 | C30H36FN3O | 2952994-34-0 | Details |
| 3′-Acetate-ATP | C12H18N5O14P3 | 90290-58-7 | Details |
| ATR-IN-21 | C23H27N7O | 2905312-17-4 | Details |
| TRV-1387 | C23H25F3N4O2 | 1569645-63-1 | Details |
| Anticancer agent 121 | 2924532-47-6 | Details |
| CDD-1733 | 2894104-33-5 | Details |
| ER degrader 6 | 2922929-62-0 | Details |
| G43-C3-TEG | 2702262-15-3 | Details |
| KRAS G12D modulator-1 | 2883034-05-5 | Details |
| PD-1/PD-L1-IN-34 | 2924403-17-6 | Details |
| mTOR inhibitor-11 | C21H26N6O2 | 3033409-32-1 | Details |
| SARS-CoV-2-IN-43 | C16H12O3 | 31356-11-3 | Details |
| Tuberculosis inhibitor 6 | C21H19N3O2S | 121041-08-5 | Details |
| Homouridine | C10H14N2O6 | 30685-57-5 | Details |
| Androgen receptor-IN-5 | C22H10Cl2F4N4OS | 1391944-16-3 | Details |
| ROCK-IN-7 | C17H17N3O2S | 2376635-95-7 | Details |
| CaSR antagonist-1 | C29H24FN3O2S | 1219811-83-2 | Details |
| Antitumor agent-114 | 2757762-91-5 | Details |
| BI 7446 | C20H22FN9O10P2S2 | 2767011-00-5 | Details |
| CDD-1845 | C34H31N5O2 | 2894104-50-6 | Details |
| JAK1-IN-11 | C26H36N6O4S | 2427608-43-1 | Details |
| Leucettinib-92 | C21H22N4OS | 2732859-57-1 | Details |
| Tankyrase-IN-5 | C17H18N2O2 | 1460285-69-1 | Details |
| MOR agonist-1 | C22H26ClFN2O2 | 2305781-14-8 | Details |
| HDAC8-IN-4 | C17H14N2O2S2 | 1600528-05-9 | Details |
| 22-(4′-py)-JA | 1178895-15-2 | Details |
| Anticancer agent 128 | 2941243-62-3 | Details |
| Antitrypanosomal agent 14 | C14H23N3OS | 1447933-37-0 | Details |
| HIV-1 protease-IN-9 | 2925381-27-5 | Details |
| RET-IN-24 | C27H26F2N8O | 2583767-68-2 | Details |
| RSV L-protein-IN-3 | 868860-35-9 | Details |
| DQn-1 | C16H14ClN5O2 | 57343-54-1 | Details |
| CFTR corrector 12 | C19H21ClN4O2S2 | 958941-60-1 | Details |
| GSK217 | C20H20N6O | 2748687-92-3 | Details |
| Anticancer agent 122 | C18H15ClN2O2S | 2924532-50-1 | Details |
| Antitumor agent-104 | C31H33FN6O3 | 2245272-16-4 | Details |
| CDD-1819 | 2894104-40-4 | Details |
| ER degrader 7 | 2922929-63-1 | Details |
| Estrogen receptor modulator 7 | 2639168-13-9 | Details |
| GPR119 agonist 2 | C23H24FN5O4S2 | 1384951-03-4 | Details |
| HL23 | C44H44N2O7 | 1448355-15-4 | Details |
| Immuno modulator-1 | C32H31FN6O4 | 2757469-20-6 | Details |
| MC-VC-PAB-Cyclohexanediamine-Thailanstatin A | C63H91N9O16 | 1609108-96-4 | Details |
| MK-8768 | C21H22F3N5O2 | 1432729-22-0 | Details |
| PPARγ agonist 8 | 1049800-41-0 | Details |
| KRAS degrader-1 | C55H57Br2ClFIN8O7 | 2795275-59-9 | Details |
| 6-Iodoamiloride | C6H8IN7O | 60398-23-4 | Details |
| Tuberculosis inhibitor 8 | C21H19FN4O | 141353-07-3 | Details |
| CDK4/6-IN-17 | C27H28F4N8 | 2035069-96-4 | Details |
| Orexin receptor modulator-1 | 2125735-57-9 | Details |
| PROTAC KRAS G12C degrader-3 | C63H75ClN14O6 | 2768099-51-8 | Details |
| SDH-IN-3 | C15H11F2N3OS | 2805297-11-2 | Details |
| USP7-IN-12 | C29H28ClFN4O2S | 2763698-01-5 | Details |
| GLX481304 | C23H29N7O | 701224-63-7 | Details |
| Product Total： Product Page： | ||||
| 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 | ||||